We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Review · June 02, 2020

A Drug Delivery Perspective on Intratumoral Immunotherapy in Renal Cell Carcinoma

Urologic Oncology: Seminars & Original Investigations

 

Additional Info

Urologic Oncology: Seminars & Original Investigations
A Drug Delivery Perspective on Intratumoral-Immunotherapy in Renal Cell Carcinoma
Urol. Oncol 2020 May 10;[EPub Ahead of Print], WS Meng, NJ Salgia, NB Pham, KY Velankar, SK Pal

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading